AzTrials
AzTrials

Periodontal DiseasesNCT04639661

Predictors of Periodontal Outcomes Post-sanative Therapy

An observational study of Periodontal Diseases and Periodontal Pocket, run by Brock University at 2 sites in Canada.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Periodontal disease is a chronic inflammatory disease of the tissues surrounding the teeth and is one of the leading causes of tooth loss. Sanative therapy (ST) is a non-surgical procedure that allows for removal of bacteria from the deep pockets that form around teeth and is the frontline treatment for periodontal… Read more about this study

Who is it for?
Ages 19 years and older
Conditions the study is for
Periodontal Diseases, Periodontal Pocket
How many people
12 participants
Where
2 sitesCanada
Study dates
25 Nov 2020to 20 Oct 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult patients who underwent sanative therapy to manage periodontal disease at this clinic 5 to 10 years before present-day appointment. Only patients who have maintained regular maintenance appointments after receiving sanative therapy will be eligible.

Who may be able to join

  • Have undergone sanative therapy (ST) in the past 5 to 10 years
  • Age > 19 years
  • Willingness and ability to provide informed consent. Participants must be able and willing to complete online questionnaires from home and give permission for access to their periodontal records from the time of their sanative therapy to present day

Who cannot join

  • Individuals with physical or mental limitations that inhibit them from conducting their own personal oral hygiene (oral hygiene is a key component in maintaining periodontal health)
  • Women who are currently pregnant or breastfeeding (hormonal changes during pregnancy are known to cause gingival inflammation)

Trial locations and contacts

2 sites in 1 country.

Canada2 sites
  • Dr. Peter C. Fritz, Periodontal Wellness & Implant Surgery

    Fonthill, Ontario, L0S1E5

  • Brock University

    St. Catharines, Ontario, L2S3A1

Other trials in Canada

About this study

Official title: Predictors of Periodontal Outcomes in Patients 5 to 10 Years Post-sanative Therapy

Periodontal disease is a chronic inflammatory disease of the tissues surrounding the teeth and is one of the leading causes of tooth loss. Sanative therapy (ST) is a non-surgical procedure that allows for removal of bacteria from the deep pockets that form around teeth and is the frontline treatment for periodontal disease. Post-ST, patients require ongoing maintenance appointments to maintain their oral health, though whether risk factors for periodontal disease remain a predictor of periodontal health post-ST has not been comprehensively investigated. Risk factors to be examined include physical activity, exercise, sedentary time, flavonoid intake, protein intake, BMI, sex, age, smoking status, and number of sites with periodontal probing depth (PPD) ≥ 4mm at baseline.

Read the detailed description

Periodontal disease is a main cause of tooth loss. Patients with periodontal disease may receive sanative therapy (ST), a deep cleaning of the teeth that helps prevent the progression of periodontal disease. Post-ST, maintenance appointments are an important part of the strategy used to help these patients prevent the progression of periodontal disease and maintain their periodontal health. Given that numerous chronic diseases, obesity, low levels of physical activity, being a smoker, poor diet, and older age are all risk factors for periodontal disease, these factors may also be predictive of worse periodontal health 5 to 10 years post-ST. Many modifiable periodontal risk factors such a physical activity, exercise, and obesity have not been studied in relation to periodontal outcomes post-ST, and other factors such as diet, sex and age have not been comprehensively studied. The primary objective of this study is to determine, at 5 to 10 years post-ST, if physical activity, exercise, sedentary time, flavonoid intake, protein intake, BMI, sex, age, smoking status, and number of sites with periodontal probing depth (PPD) ≥ 4 mm at baseline are significant predictors of periodontal health. A secondary objective is to determine if lifetime estrogen exposure impacts periodontal health in women. Periodontal health will be measured using probing depth, tooth loss, bleeding on probing and plaque index. Established questionnaires will be used to assess dietary intake, physical activity and sedentary behaviour. Within the study the investigators will also assess if and how a patient's periodontal health has been impacted by clinic closures and rescheduling of maintenance appointments that were mandated by regulatory organizations as a result of the COVID-19 pandemic. The investigators will also ask questions about changes in diet, physical activity and oral hygiene during COVID-19.

Keywords
Periodontal therapy, Flavonoids, Tea, Dietary intake, Supplements, Physical activity, Exercise, Sedentary time, Estrogen, Lifetime estrogen exposure, Periodontal maintenance
Medical subject headings
Periodontal Diseases, Periodontal Pocket, Motor Activity, Sedentary Behavior

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Probing depth

    This is a routine clinical measure of periodontal health (measured in mm)

    Measured: At maintenance appointment (present day)

  2. Probing depth

    This is a routine clinical measure of periodontal health (measured in mm)

    Measured: Pre-sanative therapy

  3. Probing depth

    This is a routine clinical measure of periodontal health (measured in mm)

    Measured: 8-12 weeks post-sanative therapy

  4. Bleeding on probing

    This is a clinical measure of inflammation and represented as the percent of bleeding sites that are measured at 6 sites per tooth

    Measured: At maintenance appointment (present day) and retrospectively from the clinical record from the time of sanative therapy (5 to 10 years ago) onwards

  5. Bleeding on probing

    This is a clinical measure of inflammation and represented as the percent of bleeding sites that are measured at 6 sites per tooth

    Measured: Pre-sanative therapy

  6. Bleeding on probing

    This is a clinical measure of inflammation and represented as the percent of bleeding sites that are measured at 6 sites per tooth

    Measured: 8-12 weeks post-sanative therapy

Secondary outcomes (6)
  1. Tooth Loss

    Will be measured as the number of teeth lost due to periodontal disease

    Measured: At maintenance appointment (present day) and retrospectively from the clinical record from the time of sanative therapy (5 to 10 years ago) onwards

  2. Tooth Loss

    Will be measured as the number of teeth lost due to periodontal disease

    Measured: Pre-sanative therapy

  3. Tooth Loss

    Will be measured as the number of teeth lost due to periodontal disease

    Measured: 8-12 weeks post-sanative therapy

  4. O'Leary Index of Plaque Control

    The patient's plaque index= the number of plaque-containing surfaces divided by the total number of available surfaces. The minimum plaque index would be 0% which represents no tooth surfaces that contain plaque/ The maximum plaque index would be 100%, which represents all surfaces of the patient's teeth containing plaque.

    Measured: At maintenance appointment (present day) and retrospectively from the clinical record from the time of sanative therapy (5 to 10 years ago) onwards

  5. O'Leary Index of Plaque Control

    The patient's plaque index= the number of plaque-containing surfaces divided by the total number of available surfaces. The minimum plaque index would be 0% which represents no tooth surfaces that contain plaque/ The maximum plaque index would be 100%, which represents all surfaces of the patient's teeth containing plaque.

    Measured: Pre-sanative therapy

  6. O'Leary Index of Plaque Control

    The patient's plaque index= the number of plaque-containing surfaces divided by the total number of available surfaces. The minimum plaque index would be 0% which represents no tooth surfaces that contain plaque/ The maximum plaque index would be 100%, which represents all surfaces of the patient's teeth containing plaque.

    Measured: 8-12 weeks post-sanative therapy

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Nov 2020
  2. Study start25 Nov 2020
  3. Primary completion20 Oct 2021
  4. Study completion20 Oct 2021

Why it stopped: Challenges with recruiting patients during the COVID-19 pandemic.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
12 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04639661
Sponsor's protocol ID
20-070
Status last verified
Nov 2021
First submitted
9 Nov 2020
Last updated
23 Nov 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Periodontal Diseases and Periodontal Pocket, run by Brock University at 2 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 23 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Challenges with recruiting patients during the COVID-19 pandemic.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Probing depth (time frame: At maintenance appointment (present day)). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Nov 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in